Skip to main content
S196 The present and the future of toxins: what's new
Saturday 28 January 2023
14:00 to 15:30
Amphi Bleu - Level 2
FOCUS SESSION

Chair(s)

Dr. Benjamin ASCHER
Dr. Benjamin ASCHER
Plastic Surgeon
France
Dr. Philippe PICAUT
Dr. Philippe PICAUT
PhD - Research
France

Lectures of the session

14:00

Introduction by the chairs

14:02

avatar_chairs Dr. Philippe PICAUT
Toxins overview: 2023 update

14:10

avatar_chairs Dr. Michael CECERLE
LetibotulinumtoxinA: what’s new 1 year after approval? (Croma)

14:10

Part 1 - Future botulinum toxins to arrive on the European market

14:18

avatar_chairs Dr. Rui AVELAR
Prabotulinumtoxin longer duration formulation first interim analysis (Evolus)

14:26

avatar_chairs Conor GALLAGHER
DaxibotulinumtoxinA for injection: the new FDA-approved long lasting botulinum toxin formulation (Revance)

14:34

Panel discussion

14:49

Part 2 - Novel botulinum toxins

14:49

avatar_chairs Mickael MACHICOANE
How to boost your usual toxin performance? (Fastox)

14:57

avatar_chairs Xiaoming LIN
RelabotulinumtoxinA: proprietary strain and liquid manufacturing process for a novel long-lasting neuromodulator (Galderma)

15:05

avatar_chairs Jon EDELSON
ET-01 – A phase 2b topical botulinum product candidate (Eirion)

15:13

Panel discussion

15:30

Recommended sessions

Have a question?

Processing, please wait...

Error

Please fill out all required fields. Here are the fields that are missing: